Nuvation Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -200.0% | – | |
| – | +0.0% | +5.5% | +320.7% | -33.6% | +35.2% | +41.6% | +14.8% | +50.0% | -324.7% | – | -200.0% | – | |
| – | -31.5% | +35.4% | +89.8% | -21.9% | +36.3% | -22.9% | +53.2% | -33.3% | -447.9% | – | -200.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -178.8% | – | – | – | -235.7% | – | -93.0% | -4,562.4% | – | -301.6% | – | – | |
| – | -40.9% | +107.7% | -100.0% | – | -91.2% | +453.8% | +151.4% | -93.4% | +641.7% | -46.1% | +0.0% | – | |
| – | – | -77.3% | +354.4% | -15.0% | +77.8% | +4.7% | +1.3% | -276.1% | – | -150.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -35.8% | -74.1% | – | -100.0% | – | -100.0% | – | – | |
| – | +55.8% | -82.5% | +12,985.7% | -156.0% | -41.5% | – | +35,196.2% | -99.7% | +1,509.4% | -99.5% | +387,465.9% | – | |
| – | – | -144.6% | – | – | – | +115.5% | +1,532.1% | -174.5% | – | -159.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -200.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.